Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
4.61T | 4.43T | 3.79T | 3.42T | 3.17T | 3.68T | Gross Profit |
4.61T | 4.43T | 3.79T | 3.42T | 3.17T | 3.68T | EBIT |
1.77T | 1.67T | 1.34T | 788.92B | 973.50B | 345.32B | EBITDA |
1.84T | 1.96T | 1.37T | 1.17T | 899.42B | 0.00 | Net Income Common Stockholders |
1.09T | 962.95B | 805.84B | 706.63B | 512.81B | 703.88B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
76.60T | 10.00T> | 73.21T | 72.19T | 69.66T | 59.41T | Total Assets |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Total Debt |
32.98T | 34.26T | 29.38T | 32.12T | 30.36T | 26.23T | Net Debt |
-43.62T | -43.89T | -46.53T | -42.67T | -42.21T | -35.53T | Total Liabilities |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Stockholders Equity |
13.78T | 14.66T | 12.68T | 12.10T | 11.83T | 10.72T |
Cash Flow | Free Cash Flow | ||||
281.76B | 4.47T | -6.19T | 1.26T | 18.47T | 6.84T | Operating Cash Flow |
281.76B | 4.86T | -5.90T | 1.55T | 18.80T | 7.09T | Investing Cash Flow |
0.00 | -918.90B | 5.93T | -2.41T | -7.68T | -3.01T | Financing Cash Flow |
0.00 | 8.09T | -357.78B | -485.34B | -562.58B | -1.02T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $78.47B | 7.58 | 18.77% | 4.33% | 10.29% | 28.54% | |
81 Outperform | $193.79B | 8.93 | 13.74% | 5.46% | 6.79% | 8.57% | |
78 Outperform | $95.84B | 11.31 | 8.86% | 2.22% | 8.69% | 50.61% | |
77 Outperform | $96.69B | 7.66 | 13.16% | 2.35% | 11.61% | 24.35% | |
71 Outperform | $144.58B | 11.65 | 9.70% | 1.85% | 13.21% | -12.06% | |
64 Neutral | $13.79B | 10.52 | 9.20% | 4.24% | 17.25% | -7.60% |